Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
Clinical trial NCT07027436 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07027436
- Sponsor
- Hamilton Health Sciences Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-07
- Primary completion
- 2027-10-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.